Hydroxychloroquine reduces congenital heart block recurrence by nearly half

A two-stage open-label trial proves efficacy of hydroxychloroquine in CHB recurrence.
A two-stage open-label trial proves efficacy of hydroxychloroquine in CHB recurrence.